On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayAug 31, 2021 1:59 pm

Microdose Psychedelic Insight’s DMT Conference set to take place on September 9-10th, 2021

Microdose Psychedelic Insights will host the upcoming DMT Conference on September 9-10th, 2021 Part of a series of deep dive events looking into various psychoactive and psychedelic substances, the DMT conference will examine the potential of DMT within today’s society The conference will play host to a number of keynote presentations and discussions delivered by some of the industry’s leading thinkers and innovators Microdose Psychedelic Insights (“Microdose”) is set to host their virtual DMT Conference on September 9-10th, 2021. The event will serve as a deep dive into the dynamic field of DMT therapeutics, featuring a number of expert panels…

Continue Reading

TuesdayAug 31, 2021 1:42 pm

FingerMotion Inc. (FNGR) Shares Progress on the NASDAQ Uplisting Application, Big Data Insights Division, in its August Corporate Update

On August 25, FingerMotion held a conference call in which it provided updates on the progress of its Sapientus division, application to uplist to the NASDAQ, and more Hosted by FingerMotion CEO Martin Shen, the corporate update also included a review of the Q1 2022 results, which marked the fourth consecutive quarter of record revenue FingerMotion received its first comment letter from NASDAQ, to which it responded promptly and efficiently The company, in collaboration with its partners, has begun translating products under the Sapientus division into an actual operational pilot FNGR will hold an AGM in November In July last…

Continue Reading

MondayAug 30, 2021 10:00 am

NECANN- Growing Local Cannabis Markets, Is The Largest Cannabis event in the East Coast, To Be Held In Boston 2021

Date: September 10-12, 2021 Exhibit Hall HoursFriday, September 10     11:00 AM – 5:00 PMSaturday, September 11    11:00 AM – 5:00 PMSunday, September 12      10:00 AM – 4:00 PM Hynes Convention Center, Boston MA Onsite Box Office opens at 9:00 am each day Cannabis cultivators, dealers, businesses, and enthusiasts are invited to attend the NECANN, on September 10-12, 2021. Operating since 2014, NECANN events are touted as one of the largest cannabis events on the east coast. The NECANN events attract a huge number of Hemp, MMJ and Cannabis industry professionals in the Northeast to their annual…

Continue Reading

MondayAug 30, 2021 9:30 am

FinovateFall 2021, A Fintech Seminar To Be Held In The World’s Financial Capital

Date: September 13-15, 2021 Venue-The Marriott Marquis Times Square, New York- Virtual only access also available On September 13-15, 2021, the FinovateFall is being held at The Marriott Marquis Times Square, New York. Organizations, financial institutions, fintech industry leaders, and finance influencers are invited to attend the FinovateFall 2021, an event that can also be accessed virtually. The event will be attended by global influencers and thinkers of the finance arena who will share their valuable insights and strategies on the latest global trends. FinovateFall offers a robust platform for the fintech fraternity to establish connections and derive ideas to…

Continue Reading

MondayAug 30, 2021 9:30 am

DGE’s 2nd Clinical Trial Agreements Conference to Negotiate Budgetary Restraints, Reduce Risks, and More in an Evolving Landscape

Date: September 16-17, 2021 Online Livestream Event – Locations will vary Dynamic Global Events (“DGE”) invites biopharma and medical device industry professionals to join them online September 16-17, 2021, for the 2nd Clinical Trial Agreements Conference. DGE’s first event was held online earlier this year and was focused greatly on the COVID-19 pandemic, the confidentiality of subject data, and the increased use of telemedicine, among other topics. The first event helped industry professionals determine what needed to be considered before entering into a clinical trial agreement. This conference features a distinguished speaking faculty ready to offer the strategies and best…

Continue Reading

MondayAug 30, 2021 9:30 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Leveraging Data to Offer Patients, Drug Manufacturers, Researchers, Better Outcomes

Avricore Health recently announced that screening had begun at 15 select Shoppers Drug Mart Pharmacies The company intends to expand its rapid diagnostics to other parts of Canada, as well as the US, UK, and EU Avricore aims to use diagnostics to generate data that it can then use to make better decisions and create outcomes  It hopes to be a tremendous contributor to the critical data pool that is going to make medicines cheaper, more effective, and get to patients quicker When Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) signed a master agreement with Shoppers Drug Mart Inc., Canada’s leading…

Continue Reading

MondayAug 30, 2021 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Applications to Support Research Phase Programs, Strengthen IP Portfolio

Company’s nonprovisional patent application includes claims to compositions, methods to support certain elements of preclinical and research programs Two international patent applications will grant Cybin the right to file future national applications into treaty member jurisdictions Cybin portfolio consists of 14 patent filings, 50-plus proprietary molecules, 50-plus preclinical studies and 4 active drug programs Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, is moving forward to progress and strengthen its IP portfolio by filing three patents this month. After receiving an international search report of its May 2021 Patent Cooperation Treaty (“PCT”) application, Cybin…

Continue Reading

MondayAug 30, 2021 9:00 am

DSG Global Inc. (DSGT), IMC Expand EV Line, Strengthen Position in Growing Market

Company is beginning to deliver vehicles on a grander scale IMC anticipates deliveries to individuals, fleets, dealers and government agencies during the second half of the year With each step forward, Imperium is seeing its dealer-candidate network of future dealers expand DSG Global (OTCQB: DSGT) and its automotive division, Imperium Motor Corp. (“IMC”), are taking significant steps forward as they strengthen their position in the growing market for smart new-energy vehicles. Imperium is working with two partners, Skywell Auto and Jonway Automotive Group, to offer 26 EV models for sale at both DSGT California facilities: the Fairfield Experience Center and…

Continue Reading

MondayAug 30, 2021 9:00 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), Committed to Fighting Global Warming Through Carbon-Free Ammonia Production

Blue and green hydrogen are the two types of hydrogen fuel types being examined for primary use – blue is less expensive but has the potential for higher greenhouse gas production, green hydrogen uses renewable energy sources like solar and wind power and creates a cleaner fuel Toyota Motor Corp. has manufactured one of the first hydrogen fuel cell-powered vehicles (Mirai), but there are only a handful of refilling stations available in Britain and three in Australia Global green ammonia market size is expected to record a CAGR growth rate of 54% from 2020 to 2025.  When combusted correctly, carbon-free…

Continue Reading

FridayAug 27, 2021 1:29 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), At the Forefront of the Psychedelic Renaissance

Psychedelics date back to ancient times, with records showing their use among the Aztecs as well as cultures in North Africa and Europe for medicinal and cultural purposes The prohibition era marked significant strides in psychedelics research, including the ultimate prohibition of the possession, sale and manufacture of psychedelics The 21st century has seen a surge in psychedelics research, a critical factor that has initiated a renaissance in this industry Tryp Therapeutics remains at the forefront of this renaissance with its commitment to identifying and developing clinical-stage compounds for diseases with high unmet medical needs, like Fibromyalgia and Eating Disorder…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217